MitoRx Therapeutics
Experienced leader in biotech IP, skilled in patent law, technology evaluation and competitive intelligence. Also Head of IP at Adaptimmune ($ADAP). Pharmacologist with 28 years industry experience who has taken two drugs from bench to market at TopoTarget (now Onxeo), research training at Yale and Cornell.